JesseWadeKellerMDMPHS

PubMed

• 2 citations
  End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
  , , , , , , , , , , , , , , , > ;Plos One. 2020 Jun 25
• 11 citations
  Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma
  Theodore S. Thomas, Suhong Luo, Patrick M. Reagan, Jesse Keller, Kristen M. Sanfilippo, Kenneth R. Carson> ;Journal of Geriatric Oncology. 2020 Jan 1
• 94 citations
  Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
  Kristen M. Sanfilippo, Suhong Luo, Tzu-Fei Wang, Mark A. Fiala, Martin W. Schoen, Tanya M. Wildes, Joseph Mikhael, Nicole M. Kuderer, Jesse Keller, Theodore S. Thomas,...> ;American Journal of Hematology. 2019 Nov 1
• 2 citations
  Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma.
  Ian Ferguson, Meghan Heberton, Leigh A. Compton, Jesse Keller, Lynn A. Cornelius> ;JAAD Case Reports. 2019 Jun 26
• 40 citations
  Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience.
  Nikolaos A. Trikalinos, Amy Zhou, Maria B. Doyle, Kathryn J. Fowler, Ashley Morton, Neeta Vachharajani, Manik Amin, Jesse Keller, William C. Chapman, Elizabeth M. Brun...> ;Journal of the National Comprehensive Cancer Network. 2018 Oct 1
• 38 citations
  Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
  Prashant Gabani, Benjamin W. Fischer-Valuck, Tanner M. Johanns, Leonel Hernandez-Aya, Jesse Keller, Keith M. Rich, Albert H. Kim, Gavin P. Dunn, Clifford G. Robinson, ...> ;Radiotherapy and Oncology. 2018 Aug 1
• 18 citations
  Heartland virus and hemophagocytic lymphohistiocytosis in immunocompromised patient, Missouri, USA
  Abigail L. Carlson, Daniel M. Pastula, Amy J. Lambert, J. Erin Staples, Atis Muehlenbachs, George Turabelidze, Charles S. Eby, Jesse Keller, Brian Hess, Richard S. Bul...> ;Emerging Infectious Diseases. 2018 May 1
• 10 citations
  Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation
  Jun Zou, Rizwan Romee, Michael Slade, Donna Phelan, Jesse Keller, Thalachallour Mohanakumar, Brenda J. Grossman> ;Bone Marrow Transplantation. 2017 Feb 20
• 102 citations
  Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is S...
  Ramzi Abboud, Jesse Keller, Michael Slade, John F. DiPersio, Peter Westervelt, Michael P. Rettig, Stephanie Meier, Todd A. Fehniger, Camille N. Abboud, Geoffrey L. Uy,...> ;Biology of Blood and Marrow Transplantation. 2016 Oct 1
• 67 citations
  Statins Are Associated With Reduced Mortality in Multiple Myeloma
  Kristen M. Sanfilippo, Jesse Keller, Brian F. Gage, Suhong Luo, Tzu-Fei Wang, Gerald Moskowitz, Jason Gumbel, Brandon Jamaal Blue, Katiuscia O'Brian, Kenneth R. Carson> ;Journal of Clinical Oncology. 2016 Sep 19
• A phase I study of thymoglobulin for relapsed or refractory multiple myeloma
  Jesse Keller, Mark A. Fiala, John F. DiPersio, Keith Stockerl-Goldstein, Ravi Vij, Coy D. Heldermon> ;Leukemia & Lymphoma. 2016 Feb 1
• 6 citations
  Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy.
  Amrita Krishnan, Ravi Vij, Jesse Keller, Binod Dhakal, Parameswaran Hari> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2016 Jan 1
• 10 citations
  Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma
  Amy Zhou, Manik Amin, Kathryn J. Fowler, Elizabeth M. Brunt, Jesse Keller, Benjamin R. Tan> ;Journal of the National Comprehensive Cancer Network. 2015 Dec 1
• 1 citations
  Risk-adapted strategies for the treatment of Hodgkin lymphoma.
  Jesse Keller, Kenneth R. Carson> ;Expert Opinion on Drug Safety. 2015 Sep 22
• 19 citations
  Targeted treatments for multiple myeloma: specific role of carfilzomib
  Dhivya Sugumar, Jesse Keller, Ravi Vij> ;Pharmacogenomics and Personalized Medicine. 2015 Jan 20
• 13 citations
  Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients
  Jesse Keller, Charalambos Andreadis, Lloyd E. Damon, Lawrence D. Kaplan, Thomas G. Martin, Jeffrey L. Wolf, Weiyun Z. Ai, Jeffrey M. Venstrom, Catherine C. Smith, Kari...> ;Journal of Geriatric Oncology. 2014 Jul 1
• 20 citations
  Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated wi...
  Pavan Kumar Bhamidipati, John F. DiPersio, Keith E. Stokerl-Goldstein, Armin Rashidi, Feng Gao, Geoffrey L. Uy, Peter Westervelt, Ravi Vij, Mark A. Schroeder, Camille ...> ;Bone Marrow Transplantation. 2014 May 19
• Outcomes following implementation of guidelines for selecting patients who require a gastrostomy tube insertion prior to start of concurrent chemoradiotherapy (CRT) fo...
  Jain VK, Hughes BGM, Brown T, Spurgin A, Hartnett GF, Keller J, Tripcony L, Hodge RA> ;J. Clin. Oncol.. 2011-05-20
• 65 citations
  Integrin α2 Mediates Selective Metastasis to the Liver
  Kiyoshi Yoshimura, Kristen Meckel, Lindsay S. Laird, Christina Y. Chia, Jang-June Park, Kelly Olino, Ryouichi Tsunedomi, Toshio Harada, Norio Iizuka, Shoichi Hazama, Y...> ;Cancer Research. 2009 Sep 15
• 801 citations
  DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
  Christine A. Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, Mingde Luo, Hisashi Abe, Clark M. Henderson, Felip Vilardell, Zheng Wang, Jesse Keller, Priya Banerjee, Jo...> ;Journal of Clinical Oncology. 2009 Apr 10
• Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
  Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS> ;J. Clin. Oncol.. 1989-06-01
• Proteinuria with disseminated neoplastic disease.
  Rudman D, Chawla RK, Nixon DW, Vogler WR, Keller JW, MacDonell RC> ;Cancer Res.. 1979-03-01
• Some effects of D-arabinosyl nucleosides on polymer syntheses in mouse fibroblasts.
  Doering A, Keller J, Cohen SS> ;Cancer Res.. 1966-12-01
• Join now to see all

Lectures

• Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018